Latest Retinitis pigmentosa Stories
In a major breakthrough in the field of regenerative medicine, scientists have for the first time created a part of the eye critical for vision using animal stem cells.
Retinitis pigmentosa is an inherited eye disorder characterized by progressive loss of vision that in many instances leads to legal blindness at the end stage.
A new implant designed to help the blind has allowed three test patients to see the shapes of objects just days after they were fitted with the device.
BOSTON, Oct. 21 /PRNewswire/ -- Dr. Tatsuo Hirose will receive the Schepens Eye Research Institute 2010 Distinguished Alumni Award at the Annual Meeting on Friday, October 22, 2010.
Today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases.
BOSTON, Aug. 18 /PRNewswire/ -- Dr. Eli Peli, senior scientist and vision rehabilitation researcher at Schepens Eye Research Institute, has won the 2010 Edwin H. Land Medal. The prize is given each year in honor of Edwin H.
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision.
Neurobiologists funded by the Office of Naval Research (ONR) have discovered a potential cure for degenerative vision diseases leading to terminal blindness.
NEW YORK, Aug.
Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness.
- A small wooded valley; a dell.
- The protecting weather-shed built around the entrance to a house.